Back
Delegates Premium Access

Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis

Session: Pharmacotherapy, fibrinolysis, and clinical registries in acute coronary syndrome
Topic: Pharmacotherapy
Speaker: Mrs Y. Wu (Taipei, TW)
Event: ESC Acute CardioVascular Care 2026

Congress Presentation

Add to my library

Like

About the speaker

Mrs Yee Jen Wu

National Taiwan University Hospital, Taipei (Taiwan)
0 follower

4 more presentations in this session

Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital

Speaker: Doctor S. Hall (New York, US)

Access
Abstract
Like
Thumbnail

Armenian national registry of myocardial infarction (ARMI): first results from a nationwide prospective stemi registry

Speaker: Doctor M. Sargsyan (Yerevan, AM)

Access
Abstract
Like
Thumbnail

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

Speaker: Doctor M. Yildirim (Heidelberg, DE)

Access
Abstract
Like
Thumbnail

Impact of P2Y12 inhibitor pretreatment before coronary angiography in high risk NSTE-ACS: A comparative cohort analysis

Speaker: Doctor L. Garcia Linacero (Madrid, ES)

Access
Abstract
Like
Thumbnail

Access the full session

Pharmacotherapy, fibrinolysis, and clinical registries in acute coronary syndrome

Speakers: Mrs Y. Wu, Doctor S. Hall, Doctor M. Sargsyan, Doctor M. Yildirim, Doctor L. Garcia Linacero
Access
Like
Thumbnail

About the event

Image

ESC Acute CardioVascular Care 2026

20 March - 21 March 2026

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources
novartis Explore sponsored resources